Our findings are in agreement with previous reports indicating that NMT1 is a cancer therapeutic target9–13, and support a general homeostatic function of NMT1 in cancer that is beyond oncoprotein myristoylation, and which could be exploited for therapeutic purposes in different cancer types. This evidence concerns the gene NMT1 and cancer.